STOCK TITAN

Precigen CFO exercises options for 53,665 shares

Three exercised option tranches were fully vested; the one-share option had a separately stated vesting schedule.

(High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PRECIGEN, INC. (PGEN) Chief Financial Officer Thomasian Harry Jr. reported exercising four option tranches on September 23, 2026, for 53,665 common shares. The shares were acquired at exercise prices of $4.72 for 10,744 shares, $2.33 for 42,918 shares, $0.96 for 2 shares, and $1.21 for 1 share; the corresponding options were disposed of in the exercises.

The options covering the first three share amounts were fully vested. The one-share option had a stated vesting schedule of 25% on April 28, 2024, followed by equal monthly installments for three years. No Rule 10b5-1 plan is reported.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Thomasian Harry Jr.
Role Chief Financial Officer
Type Security Shares Price Value
Exercise Option to Purchase Common Stock (Right to Buy) F1 10,744 $0.00 $0.00
Exercise Option to Purchase Common Stock (Right to Buy) F1 42,918 $0.00 $0.00
Exercise Option to Purchase Common Stock (Right to Buy) F1 2 $0.00 $0.00
Exercise Option to Purchase Common Stock (Right to Buy) F2 1 $0.00 $0.00
Exercise Common Stock 10,744 $4.72 $51K
Exercise Common Stock 42,918 $2.33 $100K
Exercise Common Stock 2 $0.96 $1.92
Exercise Common Stock 1 $1.21 $1.21
Holdings After Transaction: Option to Purchase Common Stock (Right to Buy) — 894,150 contracts (Direct); Common Stock — 311,914 shares (Direct)
Footnotes (2)
  1. F1. The options are fully vested.
  2. F2. The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter.
Option exercise 10,744 shares at $4.72 per share September 23, 2026
Option exercise 42,918 shares at $2.33 per share September 23, 2026
Option exercise 2 shares at $0.96 per share September 23, 2026
Option exercise 1 share at $1.21 per share September 23, 2026
Option to Purchase Common Stock (Right to Buy) financial
"Option to Purchase Common Stock (Right to Buy)"
fully vested financial
"The options are fully vested."
equal monthly installments financial
"in equal monthly installments for three years thereafter"
exercise price financial
"conversion_or_exercise_price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PGEN shares did the CFO acquire through option exercises?

Thomasian Harry Jr., PRECIGEN's Chief Financial Officer, acquired 53,665 common shares through four option exercises on September 23, 2026. The exercise prices were $4.72 for 10,744 shares, $2.33 for 42,918 shares, $0.96 for 2 shares, and $1.21 for 1 share.

Were the PGEN CFO's exercised options vested or under a 10b5-1 plan?

The options covering 10,744, 42,918 and 2 shares were fully vested. The one-share option's stated schedule provides for 25% vesting on April 28, 2024, followed by equal monthly installments for three years. No Rule 10b5-1 plan is reported.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Thomasian Harry Jr.

(Last)(First)(Middle)
20374 SENECA MEADOWS PARKWAY

(Street)
GERMANTOWN MARYLAND 20876

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/23/2026M10,744A$4.72268,993D
Common Stock09/23/2026M42,918A$2.33311,911D
Common Stock09/23/2026M2A$0.96311,913D
Common Stock09/23/2026M1A$1.21311,914D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock (Right to Buy)$4.7209/23/2026M10,744 (1)10/18/2031Common Stock10,744$0169,256D
Option to Purchase Common Stock (Right to Buy)$2.3309/23/2026M42,918 (1)02/02/2032Common Stock42,918$0157,082D
Option to Purchase Common Stock (Right to Buy)$0.9609/23/2026M2 (1)03/24/2033Common Stock2$046,813D
Option to Purchase Common Stock (Right to Buy)$1.2109/23/2026M1 (2)04/28/2033Common Stock1$0520,999D
Explanation of Responses:
1. The options are fully vested.
2. The options vest 25% on April 28, 2024 and in equal monthly installments for three years thereafter.
/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact09/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading